Breaking News, Promotions & Moves

ChargePoint Strengthens Presence in European Aseptic Manufacturing Market

Mousty and Dunne named to key posts as part of a focus on emerging aseptic markets

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contained and sterile transfer solutions provider, ChargePoint Technology, has made two appointments to reinforce its presence in aseptic manufacturing and increase its presence in France and the Benelux region.
 
ChargePoint, which manufactures material transfer/handling devices for a range of applications within the pharmaceutical, biotech, chemical and other process industries, appointed Frederic Mousty and Christian Dunne as part of a focus on emerging aseptic markets.
 
Mr. Mousty, new technical sales manager, will be based in Belgium and will lead the company’s response to the surge in demand for containment technologies used in aseptic and high potency manufacturing within France and the Benelux region. Previously, he spent over a decade working at Alfa Laval in France.
 
“Growing our presence within France and Benelux is a natural progression for us and echoes our commercial strategy to expand the company in key markets during 2019,” said Chris Eccles, chief executive officer, ChargePoint Technology. “Our focus in the France and Benelux regions means that we are ideally placed to respond to the increasing demand from the cluster of large pharma companies and Frederic’s knowledge and background ensures that these markets are in safe hands.”
 
Mr. Dunne, new global head of sterile solutions, will be responsible for growing the company’s aseptic division and working with its network of agents and distributors within this sector.
 
Mr. Eccles said, “Christian Dunne will be pivotal in driving the company’s growth and new business strategies within the aseptic markets whilst maintaining strong relationships with existing customers. He brings with him a wealth of experience in supporting customers with a range of products specialized for material handling and manufacturing processes, having worked in the industry for over two decades.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters